Research is the key to improving the lives of individuals with Angelman syndrome and to finding a cure. While we strive to provide the most up-to-date information regarding our funded research projects, we want to offer a closer look at the individuals conducting such groundbreaking work.
ASF's Researcher Spotlight provides information—both personal and professional—about our funded investigators.
Dr. Jason Shepherd didn’t originally plan on pursuing a career in Angelman syndrome research, but it is a path that he is incredibly inspired to be walking along. Growing up, Shepherd knew that he wanted to be a scientist or a doctor, but was fascinated by how the body worked and it was the brain that intrigued him most.
Dr. John Marshall is a professor of medical science in the Department of Molecular Pharmacology, Physiology and Biotechnology at Brown University in Providence, Rhode Island. He earned his Ph.D. in Neurobiology of Acetylcholine receptor from Cambridge University in England, and conducted postdoctoral training at Yale University. A major focus of his research is studying how receptors play key roles in neuronal communication, the study of which is having positive implications and revealing important discoveries about neuronal communication in Angelman syndrome.
Dr. Ype Elgersma is a Professor of Molecular Neuroscience at Erasmus Medical Center in Rotterdam. He is also the Scientific Director of ENCORE Expertise Centre for Neurodevelopmental Disorders. His current focus is trying to understand how motor deficits in Angelman syndrome arise, and whether the neurological deficits are reversible.
Dr. Scott Dindot is an Assistant Professor in the Department of Veterinary Pathobiology at Texas A&M University. He received his Ph.D. in Genetics from Texas A&M, and received postdoctoral training in Dr. Arthur Beaudet’s laboratory at Baylor College of Medicine. His current projects include: Elucidating the mechanisms regulating genomic imprinting of Ube3a in neurons, examining the efficacy of gene therapy in Angelman syndrome mice, and examining the neurological function of the human UBE3A isoforms.
Dr. Eric Klann is a Professor in the Center of Neural Science at New York University. He received his Ph.D. in Biochemistry & Molecular Biophysics from the Medical College of Virginia. Received postdoctoral training in Dr. David Sweatt's laboratory at Baylor College of Medicine. Held faculty positions in the Department of Neuroscience at the University of Pittsburgh and the Department of Molecular Physiology at Baylor College of Medicine.